Delivery Order SPE2DB22D2006-SPE2DB25FW4CW
- Not listed
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $1,187.44 to AmerisourceBergen Drug Corp for Rocuronium 100 mg/10 mL vials on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order was awarded competitively without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rocuronium is a neuromuscular blocking agent used in surgical and critical care settings,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Rocuronium 100 mg/10 mL vials with a ceiling value of $1,166.98 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 14, 2025, and performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Rocuronium 100 mg/10 ml vials with a ceiling value of $1,105.56. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded through open procurement...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Rocuronium 100 mg/10 ml vials totaling $1,166.98 under firm fixed pricing. This award represents a competitively awarded, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,228.60 to AmerisourceBergen Drug Corp for the supply of Rocuronium 100 mg/10 mL vials. This contract, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rocuronium is a neuromuscular blocking agent commonly...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Rocuronium 100 mg/10 mL vials with a ceiling value of $1,166.98 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made on a competitive,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Rocuronium 100 mg/10 mL vials with a ceiling value of $1,346.81. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the qualified vendor. The order is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.60 to AmerisourceBergen Drug Corp for the supply of Rocuronium 100 mg/10 ml vials on August 25, 2025, with completion targeted for August 26, 2025. This competitively awarded contract, issued without set-aside provisions, represents a firm fixed-price transaction for pharmaceutical delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rocuronium 100 mg/10 mL vials with a ceiling value of $1,228.60. This delivery order, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a firm fixed-price pharmaceutical supply transaction performed in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded, reflecting the contractor's capability to meet federal...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rocuronium 100 mg/10 mL vials. This competitively awarded, non-set-aside contract carries a ceiling value of $1,105.56 and is scheduled for completion by August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and holds an...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4CWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,859.18 to AmerisourceBergen Drug Corp for the supply of Rocuronium 50 mg/5 mL vials on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed price contract represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rocuronium is a neuromuscular blocking agent commonly used in anesthesia and critical care settings. As the prime contractor under the DLA's comprehensive pharmaceutical supply vehicle, AmerisourceBergen Drug Corp fulfills routine medical supply delivery orders to support military healthcare programs and the Defense Health Agency. This delivery order exemplifies the company's role in maintaining a steady supply of specialized pharmaceutical products essential to federal medical operations. The IDC vehicle enables flexible, on-demand procurement of pharmaceutical products across multiple therapeutic domains to serve defense and veteran healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/10/25 |